H2020FP7HORIZON
Boehringer Ingelheim Pharma GmbH &Co KG
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 1,588,566
- Active
- 2009 to 2025
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ENKOREPropelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments | HORIZON | 2025 | Associated partner | EUR 0 |
| NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models | HORIZON | 2024 | Associated partner | EUR 0 |
| INSPIREINnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. | H2020 | 2020 | Participant | EUR 252,788 |
| TICARDIOThrombo-inflammation in cardiovascular disease | H2020 | 2019 | Partner | EUR 0 |
| ENTRAINENdoThelial macRophage Alliance In Neuroinflammation | H2020 | 2019 | Partner | EUR 0 |
| PROTONProton transport and proton-coupled transport | H2020 | 2019 | Participant | EUR 252,788 |
| EUROoCInterdisciplinary training network for advancing Organ-on-a-chip technology in Europe | H2020 | 2018 | Partner | EUR 0 |
| BIGCHEMBig Data in Chemistry | H2020 | 2016 | Participant | EUR 463,820 |
| eCHO SystemsEnhancing CHO by Mammalian Systems Biotechnology (eCHO systems) | H2020 | 2015 | Partner | EUR 0 |
| DISCOFrom DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products | FP7 | 2013 | Participant | EUR 48,000 |
| TS-EUROTRAINInterdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders | FP7 | 2012 | Participant | EUR 249,494 |
| ALEXANDERMucus Permeating Nanoparticulate Drug Delivery Systems | FP7 | 2012 | Participant | EUR 116,100 |
| TRANSPOLTransport and signalling in Polarized Cells | FP7 | 2010 | Participant | Not stated |
| NEURASYNCAcademic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases | FP7 | 2009 | Participant | EUR 205,575 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.